INS and COVID-19: Interestingly, considering the COVID-19 severity, in patients with moderate severity disease, glycemic control was more adequate in the group treated with antidiabetic drugs with or without insulin compared to patients in the only-insulin-treated group (P = .008), whereas no difference between both groups of treatment was found in severely affected patients (P = .3).